Logo image of WGS

GENEDX HOLDINGS CORP (WGS) Stock Fundamental Analysis

NASDAQ:WGS - Nasdaq - US81663L2007 - Common Stock - Currency: USD

84.91  +5.08 (+6.36%)

After market: 85.9 +0.99 (+1.17%)

Fundamental Rating

4

Overall WGS gets a fundamental rating of 4 out of 10. We evaluated WGS against 103 industry peers in the Health Care Providers & Services industry. While WGS seems to be doing ok healthwise, there are quite some concerns on its profitability. WGS is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

WGS had positive earnings in the past year.
In the past year WGS has reported a negative cash flow from operations.
WGS had negative earnings in each of the past 5 years.
WGS had a negative operating cash flow in each of the past 5 years.
WGS Yearly Net Income VS EBIT VS OCF VS FCFWGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

WGS has a Return On Assets of -8.64%. This is in the lower half of the industry: WGS underperforms 75.73% of its industry peers.
With a Return On Equity value of -14.99%, WGS is not doing good in the industry: 64.08% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.64%
ROE -14.99%
ROIC N/A
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
WGS Yearly ROA, ROE, ROICWGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K -4K -5K

1.3 Margins

WGS has a Gross Margin of 65.26%. This is amongst the best in the industry. WGS outperforms 85.44% of its industry peers.
WGS's Gross Margin has improved in the last couple of years.
WGS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
WGS Yearly Profit, Operating, Gross MarginsWGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

6

2. Health

2.1 Basic Checks

WGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
WGS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, WGS has more shares outstanding
Compared to 1 year ago, WGS has an improved debt to assets ratio.
WGS Yearly Shares OutstandingWGS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
WGS Yearly Total Debt VS Total AssetsWGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 4.02 indicates that WGS is not in any danger for bankruptcy at the moment.
The Altman-Z score of WGS (4.02) is better than 75.73% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that WGS is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.20, WGS is doing good in the industry, outperforming 66.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 4.02
ROIC/WACCN/A
WACC9.27%
WGS Yearly LT Debt VS Equity VS FCFWGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

A Current Ratio of 3.25 indicates that WGS has no problem at all paying its short term obligations.
The Current ratio of WGS (3.25) is better than 88.35% of its industry peers.
A Quick Ratio of 3.07 indicates that WGS has no problem at all paying its short term obligations.
WGS's Quick ratio of 3.07 is amongst the best of the industry. WGS outperforms 88.35% of its industry peers.
Industry RankSector Rank
Current Ratio 3.25
Quick Ratio 3.07
WGS Yearly Current Assets VS Current LiabilitesWGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

WGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 123.85%, which is quite impressive.
Looking at the last year, WGS shows a very strong growth in Revenue. The Revenue has grown by 48.81%.
The Revenue has been growing by 9.26% on average over the past years. This is quite good.
EPS 1Y (TTM)123.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%181.82%
Revenue 1Y (TTM)48.81%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%40.35%

3.2 Future

Based on estimates for the next years, WGS will show a very strong growth in Earnings Per Share. The EPS will grow by 81.46% on average per year.
Based on estimates for the next years, WGS will show a quite strong growth in Revenue. The Revenue will grow by 18.25% on average per year.
EPS Next Y368.77%
EPS Next 2Y196.97%
EPS Next 3Y127.96%
EPS Next 5Y81.46%
Revenue Next Year27.04%
Revenue Next 2Y23.18%
Revenue Next 3Y20.84%
Revenue Next 5Y18.25%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
WGS Yearly Revenue VS EstimatesWGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
WGS Yearly EPS VS EstimatesWGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -10 -20 -30 -40

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 102.30, which means the current valuation is very expensive for WGS.
WGS's Price/Earnings is on the same level as the industry average.
WGS is valuated expensively when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 41.86, WGS can be considered very expensive at the moment.
WGS's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of WGS to the average of the S&P500 Index (37.78), we can say WGS is valued inline with the index average.
Industry RankSector Rank
PE 102.3
Fwd PE 41.86
WGS Price Earnings VS Forward Price EarningsWGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

WGS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. WGS is more expensive than 64.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 254.95
WGS Per share dataWGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

WGS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WGS's earnings are expected to grow with 127.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y196.97%
EPS Next 3Y127.96%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WGS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENEDX HOLDINGS CORP

NASDAQ:WGS (7/28/2025, 8:00:02 PM)

After market: 85.9 +0.99 (+1.17%)

84.91

+5.08 (+6.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners103.18%
Inst Owner Change-0.55%
Ins Owners1.39%
Ins Owner Change0.62%
Market Cap2.42B
Analysts84
Price Target106.66 (25.62%)
Short Float %14.72%
Short Ratio3.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)321.34%
Min EPS beat(2)277.76%
Max EPS beat(2)364.92%
EPS beat(4)4
Avg EPS beat(4)207.02%
Min EPS beat(4)67%
Max EPS beat(4)364.92%
EPS beat(8)7
Avg EPS beat(8)112.85%
EPS beat(12)8
Avg EPS beat(12)68.66%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)11%
Min Revenue beat(2)6.85%
Max Revenue beat(2)15.16%
Revenue beat(4)4
Avg Revenue beat(4)14.21%
Min Revenue beat(4)6.85%
Max Revenue beat(4)17.71%
Revenue beat(8)8
Avg Revenue beat(8)10.46%
Revenue beat(12)10
Avg Revenue beat(12)4.14%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.08%
PT rev (3m)-3.02%
EPS NQ rev (1m)-13.56%
EPS NQ rev (3m)-39.1%
EPS NY rev (1m)0.71%
EPS NY rev (3m)14.78%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)2.71%
Valuation
Industry RankSector Rank
PE 102.3
Fwd PE 41.86
P/S 7.34
P/FCF N/A
P/OCF N/A
P/B 9.41
P/tB 23.68
EV/EBITDA 254.95
EPS(TTM)0.83
EY0.98%
EPS(NY)2.03
Fwd EY2.39%
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS11.57
BVpS9.02
TBVpS3.59
PEG (NY)0.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.64%
ROE -14.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.26%
FCFM N/A
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
F-Score6
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA 6.26
Cap/Depr 49.94%
Cap/Sales 3.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.25
Quick Ratio 3.07
Altman-Z 4.02
F-Score6
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)22.03%
Cap/Depr(5y)86.79%
Cap/Sales(3y)3.57%
Cap/Sales(5y)7.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)123.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%181.82%
EPS Next Y368.77%
EPS Next 2Y196.97%
EPS Next 3Y127.96%
EPS Next 5Y81.46%
Revenue 1Y (TTM)48.81%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%40.35%
Revenue Next Year27.04%
Revenue Next 2Y23.18%
Revenue Next 3Y20.84%
Revenue Next 5Y18.25%
EBIT growth 1Y88.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year531.01%
EBIT Next 3Y133.18%
EBIT Next 5YN/A
FCF growth 1Y95.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.35%
OCF growth 3YN/A
OCF growth 5YN/A